Syntropy

Merck KGaA, Palantir's new joint venture looks to tear down cancer research data silos
By Dave Muoio | 12:17 pm | November 20, 2018
Boston-based Syntropy will create a digital platform that allows cancer researchers to share and analyze data from numerous different organizations.